Trial intelligence / Profile preview

EPOMI erythropoietin in acute myocardial infarction

2007-002902-23Phase 2Active

Sponsor
Centre Hospitalier Universitaire d'Angers
Start
Nov 2007
Modality
Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes, Colony Stimulating Factors → Cytokines & Interferons → Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 2, randomised trial of epoetin beta in myocardial infarction (MI) and acute coronary syndrome (ACS) (2 arms), sponsored by Centre Hospitalier Universitaire d'Angers. Started Nov 2007; status: active.

02

Drugs

epoetin beta
03

Conditions

myocardial infarction (MI)acute coronary syndrome (ACS)

Beyond the preview

Go deeper on 2007-002902-23.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-002902-23.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call